The FDA has classified a recall of Nexterone (amiodarone hydrochloride) 360 mg/200 mL premixed single-dose GALAXY containers, from Baxter Healthcare, as Class II. The stated reason is deviation from current good manufacturing practice, and the status is ongoing.
Class II is the middle category: it means the product may cause temporary or medically reversible harm, with a remote probability of serious consequences. It is not a withdrawal for a proven clinical injury, and it is not the same as a safety communication about the drug itself — amiodarone's pharmacology is not in question here. What is in question is this manufacturer's batches of this presentation.
The practical action is stock, not prescribing. Check whether your coronary care unit or theatre stocks Baxter premixed amiodarone in the 360 mg/200 mL GALAXY bag, and if so identify affected lot numbers through your pharmacy against the FDA enforcement record. Where the premixed presentation is unavailable, ampoule amiodarone reconstituted locally remains the alternative, with the usual care over dextrose compatibility and line choice. The recall is a US enforcement action, and whether the affected lots reached Indian supply chains is not stated in the record.
- Ask pharmacy whether the premixed GALAXY amiodarone presentation is stocked, and check lots against the enforcement listing.
- Do not change amiodarone prescribing — this concerns manufacture of one presentation, not the drug.
- Plan an alternative preparation for arrest trolleys and theatre if the premixed bag is quarantined.
- Indian distribution of the affected lots is not stated; treat it as unknown rather than assuming either way.
Why it matters
The premixed bag is what sits on the arrest trolley, so a supply interruption is a resuscitation problem rather than a formulary one.
Don't overread it
A Class II recall for manufacturing deviations is a quality action, not evidence of harm from amiodarone.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free